Jean-Pierre Sommadossi, PhD

Jean-Pierre Sommadossi, PhD

President, Chief Executive Officer and Chairman of the BoardatAtea Pharmaceuticals· In proxies 2021–2025

Pay in FY2025-19% from the year before · Atea Pharmaceuticals stock +6.6% the same year

Jean-Pierre Sommadossi, PhD was paid $3.4M in FY2025 (Dec), down 19%. Atea Pharmaceuticals stock rose 6.6% that year.

Pay$100 in the stock at the end of FY20 → $9
Pay is from the Summary Compensation Table of each Atea Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Atea PharmaceuticalsPublic company · 5 yr
    • President, Chief Executive Officer and Chairman of the Board2021 – Present · 5 yrStock in role -88%
  2. Annual MeetingPublic company
    • Director? – PresentNo stock prices for these years
  3. AteaPublic company
    • Director? – PresentNo stock prices for these years
  4. ABG Acquisition CorporationPublic company
    • Director? – PresentNo stock prices for these years
  5. Kezar Life Sciences, Inc.Public company
    • Director? – PresentNo stock prices for these years
  6. Other Public Company DirectorshipsPublic company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?